BioHealth News Archive
Addressing the needs of pediatric medicine with the Children’s Hospital Coalition powered by Phlow
RICHMOND, Va. -- The pandemic has created an ongoing need for pediatric medicine and two organizations have partnered to tackle the issue. Founder of…
Read More
Events – Alliance of Merger & Acquisition Advisors
AM&AA brings back the world of middle-market mergers and acquisitions live and in-person this summer in Dallas, Texas! Network with hundreds of decision-makers, including M&A advisors,…
Read More
Immunomic Therapeutics Announces License Agreement With Lineage Cell Therapeutics for Cancer Immunotherapy – Immunomic Therapeutics
ROCKVILLE, Md. & CARLSBAD, Calif.–(BUSINESS WIRE)– Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms,…
Read More
Biotech accelerator finishes construction, begins looking for tenants – Inside Business
A Virginia Beach biotech accelerator program announced more than five years ago as a way to attract a booming, high-salary industry to the area…
Read More
Gain Therapeutics – Gain Therapeutics Announces Multi-Target Drug Discovery Collaboration Agreement with Zentalis Pharmaceuticals
Collaboration to use Gain’s proprietary Site-Directed Enzyme Enhancement Therapy (SEE-Tx™) computational platform technology to identify new and previously difficult-to-drug oncology targets BETHESDA, Md., April…
Read More
OS Therapies Completes $6 Million Series A Funding Round
Led by Noble Capital Markets and Tichenor Ventures to Fund OST-HER2 PhIIb Trial and OST-TDC Preclinical Next Generation ADC CAMBRIDGE, Md., April 20, 2021…
Read More
The Workshop (May 13 & 14, 2021)
The purpose of this event is to bring Technology Transfer leaders, policy makers, thought leaders, and innovators in the Technology Transfer field together to…
Read More
Cellphire Therapeutics Names Michael Gaffney as Company’s New CEO
ROCKVILLE, Md., April 20, 2021 /PRNewswire/ -- Cellphire Therapeutics, Inc., a biotechnology company developing next-generation platelet-based hemostatic therapeutics for application across multiple medical indications,…
Read More
Federal Laboratory Consortium for Technology Transfer Archives · BioBuzz
The Montgomery County Economic Development Corporation (MCEDC) and the Federal Laboratory Consortium (FLC) have signed a Memorandum of Understanding (MOU) to formalize a strategic…
Read More
TEDCO’s Seed Fund Invests $200K in Maryland Technology Startup, Completing $850K Investment Round | TEDCO
COLUMBIA, Md. (April 20, 2021)—TEDCO, Maryland’s economic engine for technology companies, announced today its Seed Fund invested $200K in TargetDocs, a Maryland-based technology startup.…
Read More
Largest Venture Capital Investors in Greater D.C. – Washington Business Journal
Largest Venture Capital Investors in Greater D.C. - Washington Business Journal Image: https://www.bizjournals.com {iframe}https://www.bizjournals.com/washington/subscriber-only/2021/04/23/largest-venture-capital-investors-in.html{/iframe}
Read More
FDA approves GSK’s endometrial cancer therapy – MarketWatch
U.S.-listed shares of GlaxoSmithKline GSK, 0.12% were down 1.4% in trading on Thursday after the Food and Drug Administration said it had granted accelerated…
Read More
Chinese diagnostics company expands business to Maryland amid pandemic | Maryland Business News
Amid the international effects of the COVID-19 pandemic, Maccura Biotechnology, headquartered in the city of Chengdu in China’s Sichuan Province, is still able to…
Read More
Bethesda’s Gain Therapeutics Announces Multi-Target Drug Discovery Collaboration Agreement with Zentalis Pharmaceuticals · BioBuzz
BETHESDA, Md., April 20, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”) today announced a multi-target collaboration agreement with Zentalis Pharmaceuticals (NASDAQ:…
Read More
United Therapeutics submits new drug application to FDA to treat pulmonary arterial hypertension | WRAL TechWire
RESEARCH TRIANGLE PARK — United Therapeutics has applied for a priority review voucher and submitted a new drug application to the United States Food and…
Read More